Margot O’Neill

A phase I study of bevacizumab (B) in combination with everolimus (E) and erlotinib (E) in advanced cancer (BEE)

Karen Bullock, William P. Petros, Islam R. Younis et al. · Cancer Chemotherapy and Pharmacology · 2010 · 32 citations

Medicine, Oncology, Pharmacology +12

A Phase I Trial of the IGF-1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced Cancer

Gordana Vlahovic, Kellen L. Meadows, Ace J. Hatch et al. · The Oncologist · 2018 · 25 citations · Full text

Medicine, Oncology, Pharmacology +17

A phase Ib study of the combination regorafenib with PF-03446962 in patients with refractory metastatic colorectal cancer (REGAL-1 trial)

Jeffrey Clarke, Gerard C. Blobe, John H. Strickler et al. · Cancer Chemotherapy and Pharmacology · 2019 · 17 citations · Full text

Medicine, Oncology, Pharmacology +17

Results of a phase I study of bevacizumab (BV), everolimus (EV), and erlotinib (E) in patients with advanced solid tumors

Johanna C. Bendell, Daniel J. George, Andrew B. Nixon et al. · Journal of Clinical Oncology · 2007 · 10 citations

Medicine, Oncology, Pharmacology +15